The solid investment-grade ratings on Amgen Inc. reflect the strong performance of the company's newer products, the growing diversity of its drug portfolio, and its conservative financial policies. At the same time, the ratings are constrained by uncertainties about Amgen's still relatively narrow drug offering.
Quotes about amgens (4 Quotes)
Amgen's going to use every means at its disposal to protect its intellectual property rights and keep Roche off the market. We'll have to see how the courts interpret it, of course. This is a very real risk to the stock.
The company considered several attractive sites in other countries, but chose Ireland due to its thriving biotechnology community, infrastructure to support biologics manufacturing and attractive business climate. Our new facilities in Cork will enhance our ability to deliver on Amgen's robust pipeline.
These are the perfect places to expand because you can tap into diverse talent at each of these sites. Here in Washington, we're very excited that we're participating in Amgen's growth.